Top 50 Life Science Startup Investors in Germany (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
9 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $850k–$31M |
|
coparion
VC Fund
|
5 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
Lima Ventures
VC Fund
|
5 | Turkey, Estonia, United Kingdom | Seed, Pre-Seed | Artificial Intelligence, Software, FinTech | $20k–$697k |
|
Good Seed Ventures
VC Fund
|
5 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $55k–$50M |
|
IFB Innovationsstarter
VC Fund
|
5 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $79k–$3M |
|
CPT Capital
VC Fund
|
4 | United States, Israel, United Kingdom | Seed, Series A, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Grazia Equity
VC Fund
|
4 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
Agronomics
VC Fund
|
4 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Entrepreneurs First
VC Fund
|
3 | United Kingdom, United States, India | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $55k–$30M |
|
Elevat3 Capital
VC Fund
|
3 | Germany, United Kingdom | Series A, Series B, Series D | E-Commerce, Life Science, Biotechnology | $45M–$165M |
|
Inflection
VC Fund
|
3 | United States, Germany, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Blockchain, Cryptocurrency, Software | $500k–$28M |
|
IBB Ventures
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$11M |
|
b.value AG
VC Fund
|
3 | Germany, Poland | Seed, Series A | Biotechnology, Manufacturing, Chemical | $541k–$39M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Lowercarbon Capital
VC Fund
|
3 | United States, United Kingdom, France | Seed, Series A, Series B | Renewable Energy, Energy, Biotechnology | $3M–$150M |
|
Die Brückenköpfe
VC Fund
|
2 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $2M–$17M |
|
Almaro Holding AG
VC Fund
|
2 | Germany | Seed | Video Games, Life Science, Therapeutics | $1.1M–$1.4M |
|
Catalpa Ventures Family Office
VC Fund
|
2 | Germany, Luxembourg, The Netherlands | Seed, Angel, Venture - Series Unknown | Software, Information Technology, B2B | $1.3M–$1.4M |
|
Investitionsbank Berlin
VC Fund
|
2 | Germany, Canada | Grant, Seed, Series A | Software, Information Technology, Artificial Intelligence | $18k–$19M |
|
Thor Bjorgolfsson
Angel
|
2 | United Kingdom, Germany | Seed, Series A, Series C | Big Data, TV, B2B | $26M–$26M |
|
Chemovator
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Software, Manufacturing, Advanced Materials | $975k–$3.7M |
|
Happiness Capital
VC Fund
|
2 | United States, Germany, United Kingdom | Series A, Seed, Series B | Biotechnology, Food and Beverage, Health Care | $2.2M–$61M |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Angel, Pre-Seed | Health Care, Medical Device, Medical | $1.5M–$1.5M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
1kx
VC Fund
|
2 | United States, Germany, Singapore | Seed, Series A, Venture - Series Unknown | Blockchain, Cryptocurrency, Software | $1.8M–$40M |
|
Shine Capital
VC Fund
|
2 | United States, Spain, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $3.5M–$71M |
|
Zee Prime Capital
VC Fund
|
2 | United States, United Kingdom, Singapore | Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $2M–$43M |
|
Magnetic Capital
VC Fund
|
2 | Germany, United States, Canada | Seed, Pre-Seed, Series A | Software, Apps, FinTech | $1.2M–$35M |
|
Balaji Srinivasan
Angel
|
2 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $650k–$28M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
EQT Group
VC Fund
|
2 | Germany | Series A | Life Science, Biotechnology, Food and Beverage | $50M–$50M |
|
TechOne VC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed | Software, SaaS, Information Technology | $30k–$2.4M |
|
Dr Guntard Gutmann
Angel
|
2 | Germany | Convertible Note, Venture - Series Unknown | Health Care, Life Science, Therapeutics | |
|
Holger Hübner
Angel
|
2 | Germany | Seed, Pre-Seed | B2B, SaaS, Audio | $177k–$1.1M |
|
Ananda Impact Ventures
VC Fund
|
2 | Germany, United Kingdom, Finland | Seed, Series A, Series B | Health Care, Software, Information Technology | $1.6M–$53M |
|
Carsten Maschmeyer
Angel
|
2 | Germany, Austria, Switzerland | Seed, Angel, Series A | Software, Artificial Intelligence, Information Technology | $89k–$24M |
|
Ersin Pamuksüzer
Angel
|
2 | Turkey, Germany | Seed, Series A | Education, Life Science, Virtual Reality | $300k–$500k |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$30M |
|
MediVentures
VC Fund
|
2 | Germany | Seed, Series A, Venture - Series Unknown | Wellness, Health Care, Biotechnology | $2.3M–$17M |
|
The LAO
VC Fund
|
2 | United States, Singapore, Switzerland | Seed, Series A, Venture - Series Unknown | Blockchain, Cryptocurrency, Software | $100k–$30M |
|
Albert Wenger
Angel
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Software, Internet, Analytics | $650k–$30M |
|
hiVC
VC Fund
|
2 | Turkey, United States, Estonia | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $175k–$1.2M |
|
Nico Wittenborn
Angel
|
2 | United States, Germany, France | Seed, Series A, Series B | Software, Apps, Wellness | $1.6M–$88M |
|
KfW
VC Fund
|
2 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Michael Novogratz
Angel
|
2 | United States, India, Germany | Seed, Series A, Series B | Blockchain, Cryptocurrency, FinTech | $1.1M–$150M |
|
Lionheart Ventures
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Wellness | $25k–$50M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Boost VC
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Virtual Reality | $100k–$8.9M |
|
Merck
VC Fund
|
2 | United States, Germany, China | Grant, Seed, Series A | Biotechnology, Pharmaceutical, Medical | $25k–$84M |
| Access all 333 investors in Germany Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 713
- Round size: Seed $850k–$6.9M; Series A $3.1M–$31M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Coredinate — COREDINATE is a fully integrated, professional and innovative solution for security companies, maintenance companies and care providers that helps optimize your processes, help you maintain your quality, and help you satisfy your customers. Whether it's control system, tour planning, task management or event capture: COREDINATE security ,maintenance or maintenance automates all your daily tasks and optimizes monitoring
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed
- Geography: Turkey, Estonia, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $20k–$697k; Pre-Seed $50k–$100k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — heybooster is the creator of a platform for marketing analysis that aids e-commerce managers in finding chances for revenue growth and in making better choices. It provides clients with digital reporting, online meetings, online communication, an online project management system, and an online playbook that helps them discover problems, findpossibilities for revenue growth, and cut expenses.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 39
- Round size: Seed $55k–$7M; Series A $7.5M–$50M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 90
- Round size: Seed $365k–$3M; Grant $79k–$178k
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 63
- Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 85
- Round size: Seed $1.1M–$8.2M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
- XO Life — XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.
- Patronus Group — Rethinking elderly healthcare
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 48
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces guilt-free meat. Meatable is a company that creates manufactured meat using stem cell technology. By employing pluripotent stem cells, which have the potential to transform any type of cell from muscle to fat without serum, the company's method eliminates the need to remove any tissue from ananimal, allowing consumers to have sustainable food.
- SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
- Meatly — Good Dog Food creates cultivated meat for healthy pets and a healthy planet
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 447
- Round size: Seed $567k–$6.7M; Pre-Seed $55k–$2.9M; Series A $5.1M–$30M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- Sourcepulse — Your early warning system for software delivery (YC S23)
- EverSettled — Navigate the probate process with confidence. We provide a free checklist, guidance, and support to help families find clarity in the chaos of loss.
- Peripheral Labs — Peripheral Labs provides technology for live media and spatial intelligence.
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more...Investment focus
- Industry: E-Commerce, Life Science, Biotechnology
- Stage:Series A, Series B, Series D
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $45M–$165M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 45
- Round size: Seed $2M–$13M; Pre-Seed $500k–$4.3M; Venture - Series Unknown $5.4M–$28M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — raised $40M in 2022
Portfolio highlights
- Ubitium — Ubiquitous computing, universal RISC-V microprocessor
- Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
- Fabric Cryptography — Building towards a trustless future with custom chips for advanced cryptography.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 250
- Round size: Seed $1M–$4.6M; Series A $2.3M–$11M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $120M in 2022
Portfolio highlights
- KAZIMI — KAZIMI is a cybersecurity startup that helps app developers protect and verify their first-party data.
- Nenna AI — Nenna AI is a powerful AI enablement platform designed for the secure application of AI technologies.
- Jurafuchs — Jurafuchs provides legal education via a mobile app.
b.value AG are into Biotechnology investments.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Chemical
- Stage:Seed, Series A
- Geography: Germany, Poland
Investor stats
- Total investments: 14
- Round size: Seed $541k–$2.5M; Series A $3M–$39M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 107
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 225
- Round size: Seed $3M–$12M; Series A $11M–$50M; Series B $21M–$150M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $11M in 2025
Portfolio highlights
- Terraton — Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.
- River — Empowering people, improving lives.
- Antora Energy — Antora converts low-cost, intermittent renewable electricity into a reliable, on-demand source of zero-emissions industrial heat and power.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Seed $2M–$2.4M; Series A $5.7M–$17M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- keleya — Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany.
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
ALMARO Holding AG hat den Sitz in Zug. Sie ist eine Aktiengesellschaft und in der Branche «Betreiben von übrigen Finanzinstitutionen» tätig.
Show more...Investment focus
- Industry: Video Games, Life Science, Therapeutics
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Seed $1.1M–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
Catalpa Venture is a seed investor based in Luxembourg
Show more...Investment focus
- Industry: Software, Information Technology, B2B
- Stage:Seed, Angel, Venture - Series Unknown
- Geography: Germany, Luxembourg, The Netherlands
Investor stats
- Total investments: 7
- Round size: Seed $1.3M–$1.4M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- Magic Horizons — Magic Horizons is building a global platform for holistic relaxation and mental health in VR, based on scientific research and a study by Humboldt-Universität zu Berlin. Magic Horizons offers a unique opportunity for relaxation and mental health in VR for every stressed out person worldwide. The result of our work at Magic Horizons are deeprelaxation states at the touch of a button.
- Mädchenflohmarkt — Mädchenflohmarkt (Meaning: Girls Fleamarket) was founded in 2012 by Peter Ambrozy, Maria Spilka and Thorsten Lückemeier. The Stuttgart-based company operates an online marketplace for used women's fashion. The platform offers not only a fashion-focused marketplace for private buyers and sellers, but also a so-called "conciergeservice". Mädchenflohmarkt offers the concierge service to users wanting to sell their goods on the platform, without listing their goods themselves. These sellers send their items to the Mädchenflohmarkt office, where they are photographed, listed and sold on the platform.Already after 4 months of operation the young start-up reached high virality through its facebook group (215k Fans) and German mass-media coverage and will continue its efforts in a social and curated shopping approach to women. A relaunch is planned for December 2012.
Investitionsbank Berlin (IBB) is the subsidy bank of the Federal Land of Berlin. With its newly orientated economic support and subsidy policy, it actively contributes towards developing Berlin as a business and industry location.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Grant, Seed, Series A
- Geography: Germany, Canada
Investor stats
- Total investments: 59
- Round size: Seed $566k–$2.4M; Grant $18k–$1.4M; Series A $2.2M–$19M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Quantune — A new Foundation for Human Health.
- Level Nine — Level Nine specializes in bio-nanotechnology and quantum chemistry, developing next-generation catalysts known as nanozymes.
- muffintech — Generative AI for the insurance industry. Unleash the full potential of your employees and offer your customers an unmatched user experience.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more...Investment focus
- Industry: Big Data, TV, B2B
- Stage:Seed, Series A, Series C
- Geography: United Kingdom, Germany
Investor stats
- Total investments: 6
- Round size: Series A $26M–$26M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Chemovator is an incubator of chemistry businesses. It is the business incubator of BASF.
Show more...Investment focus
- Industry: Software, Manufacturing, Advanced Materials
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$3.7M; Pre-Seed $975k–$2.4M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
- Replique — Replique is an online first fully encrypted 3D printing platform that makes spare part management more sustainable to large OEMs.
- Spark e-Fuels — We build technologies for affordable, scalable and sustainable e-fuels production, to enable net-zero aviation today.
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 40
- Round size: Seed $2.2M–$9.3M; Series A $10M–$45M; Series B $8.7M–$61M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
- Project Eaden — PROJECT EADEN combines pioneering technology and engineering expertise with an immense love for food and lust for life. For full indulgence. With zero guilt.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Angel, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.5M–$1.5M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health develops digital health application to support treatment for patients and therapists alike.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — We build causal disease models to help pharmaceutical and biotech companies find promising drug targets and new indications for existing assets.
1kx is a research-driven global investment firm making trust instant, open, and programmable, with 160+ investments since 2018 across DeFi, stablecoins, and onchain infrastructure.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Germany, Singapore
Investor stats
- Total investments: 183
- Round size: Seed $1.8M–$11M; Series A $5M–$28M; Venture - Series Unknown $3M–$40M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
- KOR Protocol — KOR Protocol is a decentralized intellectual property (IP) infrastructure designed to empower creators, protect rights, and enable seamless collaboration and monetization of IP assets across various industries, including music, film, TV, gaming, and art. Backed by notable entities like Animoca Brands, Republic, Niantic, Sfermion, Solana, andprominent creators such as Black Mirror, Disclosure, deadmau5, and Richie Hawtin, KOR leverages blockchain, AI, and DeFi to offer a transparent, efficient, and scalable environment for IP expansion.
- Freehand — AI Teams for Complex Spend Management
Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to build iconic businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 78
- Round size: Seed $3.5M–$21M; Series A $12M–$25M; Series B $10M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $1M in 2026
Portfolio highlights
- Antares — Factory-produced, deployable fission microreactors to provide strategic energy for mission-critical systems across Earth, space, and underseas.
- Walden Robotics — Walden Robotics is an industrial robotics company that builds and deploys general-purpose, semi-humanoid robots for manufacturing and logistics.
- Turnout — Turnout Technologies is a technology related company.
Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 95
- Round size: Seed $2M–$9M; Series A $5M–$43M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- TrueDAO — TrueDAO is a new-generation AI-native decentralized autonomous financial infrastructure. Built on the underlying logic of DAO community co-governance, it leverages smart contracts to construct an on-chain financial system integrating AI algorithm scheduling, staking, and dynamic protection. It optimizes economic parameters and asset strategies inreal time via AI models, delivers low-volatility and sustainable value growth paths for digital assets, and pioneers an innovative paradigm of autonomous finance.
- Cryopets — Pausing biological time with cryosleep for pets
- Share — From subsea cables to last-mile networks, Share coordinates fragmented infrastructure into a single ecosystem.
We are a global technology investor, sponsoring true progress.
Show more...Investment focus
- Industry: Software, Apps, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, Canada
Investor stats
- Total investments: 30
- Round size: Seed $1.2M–$15M; Pre-Seed $1.2M–$2.6M; Series A $16M–$35M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Mabyduck — Mabyduck makes it easy to evaluate AI generated content.
- Pluto.markets — Pluto is the modern investment app for the 100m Europeans living in countries without the EUR.
- Tytan Technologies — TYTAN Technologies builds autonomous interceptors engineered for the realities of modern drone warfare.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 275
- Round size: Seed $2.3M–$15M; Pre-Seed $650k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
- Dirac Labs — Universal Navigation Powered by Quantum Sensing & AI
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $236M in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
EQT is a private equity firm that invests in companies and regions where there is an industrial approach.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $50M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
TechOne VC is a venture capital firm. It invests in innovative tech startups founded by visionary entrepreneurs solving global problems, to deliver superior returns for our investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 72
- Round size: Seed $115k–$2.4M; Pre-Seed $30k–$605k
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- Co-one — Co-one empowers businesses to unlock the full potential of Generative AI. We provide data-driven solutions for LLM development, including evaluation and dataset generation.
- Getmobil — Getmobil operates a smart device platform for buying and selling secondhand cellphones, laptops, and tablets. The company's platform repairs defective devices as quickly as possible offers a wide selection of device accessories, buys used electronic devices in good condition from consumers, determines the problems by passing them throughextensive tests, repairs them with an expert technical team, and resells them, allowing consumers to get a new or refurbished product at an affordable, reliable, and competitive price.
- Spiky.AI — Spiky.ai delivers real-time coaching, CRM sync, and multilingual AI insights to boost sales performance and streamline meetings.
Dr Guntard Gutmann
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Convertible Note, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Holger Hübner
Show more...Investment focus
- Industry: B2B, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 5
- Round size: Seed $560k–$1.1M; Pre-Seed $177k–$342k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 72
- Round size: Seed $1.6M–$18M; Series A $3.9M–$17M; Series B $7.3M–$53M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $85M in 2026
Portfolio highlights
- AIRMO — AIRMO is supporting the direct emitters, decision makers and financial institutions to efficiently transition to Net-0 by monitoring their direct emissions from space. With our roots in innovation and a commitment to environmental responsibility, we aim to revolutionize GHG monitoring through advanced satellite technology, proprietary LiDARinstrument and data analytics. We exist to monitor and manage humanity's impact on Earth.
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
- Entelo Bio — Precision Medicine
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Angel, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 83
- Round size: Seed $116k–$4.2M; Angel $89k–$548k; Series A $1.6M–$24M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
- Finperks — finperks is a prepaid infrastructure API for banks, neobanks, HR platforms, etc. in Europe. Access 1000+ brands across 30+ countries. Simplify contracts, settlements, and integrations to scale your prepaid, cashback, and employee benefits solutions.
- admark.ai — admark.ai combines cutting-edge AI language models with social media data
Ersin Pamuksüzer
Show more...Investment focus
- Industry: Education, Life Science, Virtual Reality
- Stage:Seed, Series A
- Geography: Turkey, Germany
Investor stats
- Total investments: 5
- Round size: Seed $300k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aposto — All-in-one media service currently based in Istanbul, Turkey.
- VRLab Academy — VRLab Academy | Virtual Experiments
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 95
- Round size: Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
MediVentures is an investment firm.
Show more...Investment focus
- Industry: Wellness, Health Care, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 8
- Round size: Seed $2.3M–$3.6M; Series A $4.2M–$17M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Brainjo — Brainjo is a digital health company that develops virtual reality–based applications designed to support mental health and cognitive training through immersive experiences. The company’s platform focuses on evidence-based therapies and uses gamification techniques to improve user engagement and adherence to treatment programs. Its solutions includevirtual reality training tools that combine cognitive exercises with physical activity, enabling users to train memory, coordination, and problem-solving skills within interactive environments. Brainjo is also involved in developing digital therapeutics, including applications for conditions such as ADHD, which are intended to complement traditional therapy and may be integrated into healthcare systems. The company collaborates with healthcare experts, researchers, and industry partners to translate scientific insights into practical therapeutic applications delivered through its virtual reality platform.
- XO Life — XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A venture DAO supporting the Ethereum Ecosystem
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Singapore, Switzerland
Investor stats
- Total investments: 150
- Round size: Seed $1M–$8.5M; Series A $4.4M–$30M; Venture - Series Unknown $100k–$24M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Bio.xyz — Biotech's new financial layer.
- Recall Labs — Textile is building new digital experiences by focusing on user privacy, transparency, and decentralization.
- Blackbird — We believe the next great hospitality technology platform should connect restaurants and their customers directly, in meaningful and ongoing ways. Blackbird is founded by a team with a passion for restaurants and a track record of using technology to solve problems.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more...Investment focus
- Industry: Software, Internet, Analytics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 110
- Round size: Seed $650k–$16M; Series A $1M–$23M; Series B $4.3M–$30M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Brale — One regulated system for stablecoin issuance, custody, payments, and compliance. 75+ programs in production across 45 US jurisdictions. SOC 2 Type II. Book a demo.
- Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
- Phlair — 77NEKO menjadi salah satu akses asli untuk bermain game online yang menghasilkan sulthan dengan secara sekejap. Bukan hanya itu tapi 77neko sering memberikan bonus yang gokil seperti petir merah yang tak terhingga, cashback 100% hingga spin gratis di setiap permainan.
hiVC is an early-stage venture capital that connects early-stage startups with winning business models to achieve global success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 20
- Round size: Seed $175k–$1.2M; Pre-Seed $200k–$660k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Kidokit — Kidokit is a child development and parent support application that promotes the growth of infants and kids from one to six years old.
- Varsapp — Varsapp is a data-driven rental and resale platform helping brands gain consumer insights, increase conversions, and reduce waste. Through its B2B2C model, brands can offer products for short-term rentals, allowing users to try before they buy.With over 200,000 users and partnerships. Varsapp enables brands to test demand, build loyalty, andmonetize refurbished or excess inventory via its newly launched Varsapp Market.Consumers rent high-quality items—especially in home appliances, electronics, and lifestyle categories—and decide whether to return or purchase.Currently active in Turkey and expanding into Eastern Europe and Central Asia, Varsapp supports circular consumption while generating measurable impact for both brands and users.
- VRLab Academy — VRLab Academy | Virtual Experiments
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Industry: Software, Apps, Wellness
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, France
Investor stats
- Total investments: 47
- Round size: Seed $1.6M–$8.5M; Series A $6.9M–$40M; Series B $7.5M–$88M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Mirage — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 162
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — Empowering a sustainable digital society by enabling infrastructure where it is needed.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, FinTech
- Stage:Seed, Series A, Series B
- Geography: United States, India, Germany
Investor stats
- Total investments: 34
- Round size: Seed $1.1M–$8M; Series A $11M–$38M; Series B $15M–$150M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Curative — Get on-the-go COVID-19 testing and other essential health services, wherever you are.
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- Mansa — Built by Black creators with a passion for making culture-positive content, Mansa is the only place to stream the best in Global Black stories
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk. We do this by supporting the wise development of transformative technologies. Our main areas of investment focus are transformative artificial intelligence and frontier mental health technologies.Leading academics estimate a 1-in-6 chance ofhuman extinction by the year 2100, largely driven by risks from emerging technologies. And now, with the exponential growth of AI, predictions are getting worse. Our startups are part of the solution. We invest in exceptional, ethical founders who are developing transformative technologies that have the potential to impact humanity on a meaningful scale, while generating attractive returns for our LPs.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 42
- Round size: Seed $2.3M–$11M; Series A $25k–$50M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Piramidal — Piramidal offers artificial intelligence software that transforms brain activity into easy-to-understand health data to help diagnose neurological diseases.
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 186
- Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
- Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Virtual Reality
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 383
- Round size: Seed $235k–$6.6M; Pre-Seed $100k–$3M; Venture - Series Unknown $1M–$8.9M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely actively investing — fresh fund, raised $88M in 2025
Portfolio highlights
- Claryx — The hospital immune system. Claryx detects each infection, traces how it's spreading, recommends a response, and confirms that it's gone.
- SkinBit — SkinBit is a healthtech company that develops AI-powered skin cancer detection, digital mapping, and health monitoring solutions.
- Intrinsic Power — AI-managed high-voltage power & energy unlocking 40% more capacity without costly infrastructure overhauls.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across Healthcare, Life Science and Electronics.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Medical
- Stage:Grant, Seed, Series A
- Geography: United States, Germany, China
Investor stats
- Total investments: 16
- Round size: Seed $25k–$4.7M; Grant $29k–$60k; Series A $25M–$84M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Proteologix — Proteologix is a precision immunology company powered by proprietary multi-specific antibody technologies. The company is dedicated to the discovery and development of safe and convenient therapeutics that target multiple disease-driving pathways to potentially deliver high-bar efficacy for patients with immune-mediated diseases.
- Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
- Ambrosia Biosciences — Drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
Life Science Investor funding in Germany at a glance
Stats across 177 deals from 333 investors.
Access all 333 investors in Germany Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 333 investors investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!